Exhibition Report: Participated in the 2nd AMED SCARDA Joint Symposium
From March 17 to 19, 2025, our colleagues Ozawa and Tatsukawa participated in the 2nd AMED SCARDA “Project for Formation of World-Leading Research and Development Centers for Vaccine Development” Joint Symposium, held at the Kobe International Conference Center in Hyogo Prefecture.
This symposium was organized by the Advanced Research & Development Programs Center for Vaccines (SCARDA) of the Japan Agency for Medical Research and Development (AMED), with the aim of sharing the latest research findings and technologies related to vaccine development and further strengthening collaboration.
Our company presented a corporate exhibition and poster under the theme “Autonomous Optimization of Vaccine Development Processes Using AI: Case Studies on Patient Dosing Schedules and Optimal Culture Medium Composition Exploration.” We introduced applications of our solution “Epistra Accelerate” to vaccine development and life sciences, and engaged in active discussions with attendees.
Related Articles
Won Grand Prix in the 7th IP BASE AWARD Startup Category Hosted by the Japan Patent Office
On March 3, 2026, Epistra Inc. won the Grand Prix in the startup category at the '7th IP BASE AWARD' ceremony hosted by the Japan Patent Office.
Jikkenigaku Special Issue 'AI and Data-Driven Drug Discovery Research' Published — CTO Tsuzuki Authors Chapter on AI-Driven Drug Target Discovery
In 'Jikkenigaku Special Issue: AI and Data-Driven Drug Discovery Research' published by Yodosha, our CTO Taku Tsuzuki authored a chapter on AI-driven knowledge mining for drug target discovery.
Speaking Engagement: Delivered Keynote at the 10th Cell Manufacturing Kotozukuri Symposium
On March 4, 2026, CEO Yosuke Ozawa delivered a keynote speech on optimizing cell manufacturing processes using AI and robotics at the '10th Cell Manufacturing Kotozukuri Symposium' hosted by Osaka University.